Pancreatic pseudocyst following acute pancreatitis induced by L-asparaginase treatment

S. G. Berrak, C. Canpolat, P. Berik, G. Kiyan

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The usefulness of L-asparaginase as a chemotherapeutic agent has been established for the treatment of various lymphoproliferative disorders including acute lymphoblastic leukemia and lymphoma. Pancreatitis is well recognized as a potential complication in 2% to 16% of patients undergoing treatment with L-asparaginase and the reported cases have usually been self-limited. Less well appreciated is the progression of such pancreatitis in some patients to pseudocyst formation which may sometimes necessitate surgical intervention. Only nine cases of pancreatic pseudocyst secondary to L-asparaginase have been reported so far. Eight of nine reported cases of pancreatic pseudocyst required surgical intervention. Our patient is the second case in whom non-surgical management was sufficient.

Original languageEnglish (US)
Pages (from-to)413-416
Number of pages4
JournalInternational Journal of Pediatric Hematology/Oncology
Issue number5-6
StatePublished - Dec 1 2001


  • Acute pancreatitis
  • L-asparaginase
  • Pancreatic pseudocyst

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Cancer Research


Dive into the research topics of 'Pancreatic pseudocyst following acute pancreatitis induced by L-asparaginase treatment'. Together they form a unique fingerprint.

Cite this